2-oxo-2,3-dihydro-1H-benzimidazole-5-sulfonyl chloride, 95.0%, 250mg

1,2-Diméthoxyéthane, min.99%, pour la synthèse, 500 ml, emballage en verre

2-(2-(2-Methoxyethoxy)ethoxy)acetic acid, 90%, 100g

4-(4-methylpiperidin-1-yl)-6-piperazin-1-ylpyrimidine, 95.0%, 500mg

2,4-Dimethyl-1H-pyrrole-3-carbonitrile, 95.0%, 250mg

2-Chloro-3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, 97.0%, 5g

(S)-tert-Butyl 2-(bromomethyl)azetidine-1-carboxylate, 97%, 250mg

4-amino-1-((2R,3R,4R,5R)-4-((tert-butyldimethylsilyl)oxy)-5-(((tert-butyldiphenylsilyl)oxy)methyl)-5-(chloromethyl)-3-fluorotetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 97%, 500mg

Methyl 2-(6-fluoropyridin-2-yl)acetate, 97%, 5g

2,4-dioxo-1,3-diazaspiro[4.5]decane-8-carboxylic acid, 95.0%, 500mg

5-Bromo-2,3-diphenylpyrazine, 97.0%, 10g

4-Nitro-5-(propan-2-yl)-1H-pyrazole-3-carboxylic acid, 95.0%, 500mg

Di-tert-butyl 4-amino-4-(3-(tert-butoxy)-3-oxopropyl)heptanedioate, 97%, 1g